1231 related articles for article (PubMed ID: 23897323)
21. Antifibrinolytics for heavy menstrual bleeding.
Bryant-Smith AC; Lethaby A; Farquhar C; Hickey M
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD000249. PubMed ID: 29656433
[TBL] [Abstract][Full Text] [Related]
22. Epsilon-aminocaproic acid versus tranexamic acid in total knee arthroplasty: a meta-analysis study.
Riaz O; Aqil A; Asmar S; Vanker R; Hahnel J; Brew C; Grogan R; Radcliffe G
J Orthop Traumatol; 2019 Jul; 20(1):28. PubMed ID: 31321578
[TBL] [Abstract][Full Text] [Related]
23. Pathogen-reduced platelets for the prevention of bleeding.
Estcourt LJ; Malouf R; Hopewell S; Trivella M; Doree C; Stanworth SJ; Murphy MF
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD009072. PubMed ID: 28756627
[TBL] [Abstract][Full Text] [Related]
24. Antifibrinolytic drugs for acute traumatic injury.
Ker K; Roberts I; Shakur H; Coats TJ
Cochrane Database Syst Rev; 2015 May; 2015(5):CD004896. PubMed ID: 25956410
[TBL] [Abstract][Full Text] [Related]
25. Prophylactic platelet transfusions prior to surgery for people with a low platelet count.
Estcourt LJ; Malouf R; Doree C; Trivella M; Hopewell S; Birchall J
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD012779. PubMed ID: 30221749
[TBL] [Abstract][Full Text] [Related]
26. Use of platelet transfusions prior to lumbar punctures or epidural anaesthesia for the prevention of complications in people with thrombocytopenia.
Estcourt LJ; Malouf R; Hopewell S; Doree C; Van Veen J
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011980. PubMed ID: 29709077
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological interventions for the prevention of bleeding in people undergoing definitive fixation or joint replacement for hip, pelvic and long bone fractures.
Gibbs VN; Geneen LJ; Champaneria R; Raval P; Dorée C; Brunskill SJ; Novak A; Palmer AJ; Estcourt LJ
Cochrane Database Syst Rev; 2023 Jun; 6(6):CD013499. PubMed ID: 37272509
[TBL] [Abstract][Full Text] [Related]
28. Drugs to reduce bleeding and transfusion in major open vascular or endovascular surgery: a systematic review and network meta-analysis.
Beverly A; Ong G; Kimber C; Sandercock J; Dorée C; Welton NJ; Wicks P; Estcourt LJ
Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013649. PubMed ID: 36800489
[TBL] [Abstract][Full Text] [Related]
29. Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.
Radford M; Estcourt LJ; Sirotich E; Pitre T; Britto J; Watson M; Brunskill SJ; Fergusson DA; Dorée C; Arnold DM
Cochrane Database Syst Rev; 2024 May; 5(5):CD011305. PubMed ID: 38780066
[TBL] [Abstract][Full Text] [Related]
30. Comparison of ε-Aminocaproic Acid and Tranexamic Acid in Reducing Postoperative Transfusions in Total Hip Arthroplasty.
Churchill JL; Puca KE; Meyer ES; Carleton MC; Truchan SL; Anderson MJ
J Arthroplasty; 2016 Dec; 31(12):2795-2799.e1. PubMed ID: 27286909
[TBL] [Abstract][Full Text] [Related]
31. Comparing ε-Aminocaproic Acid and Tranexamic Acid in Reducing Postoperative Transfusions in Total Knee Arthroplasty.
Churchill JL; Puca KE; Meyer E; Carleton M; Anderson MJ
J Knee Surg; 2017 Jun; 30(5):460-466. PubMed ID: 27699724
[TBL] [Abstract][Full Text] [Related]
32. Restrictive versus liberal red blood cell transfusion strategies for people with haematological malignancies treated with intensive chemotherapy or radiotherapy, or both, with or without haematopoietic stem cell support.
Estcourt LJ; Malouf R; Trivella M; Fergusson DA; Hopewell S; Murphy MF
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD011305. PubMed ID: 28128441
[TBL] [Abstract][Full Text] [Related]
33. Preventing perioperative bleeding in patients with inherited bleeding disorders.
Watterson C; Beacher N
Evid Based Dent; 2017 Mar; 18(1):28-29. PubMed ID: 28338025
[TBL] [Abstract][Full Text] [Related]
34. Prophylactic plasma transfusion for patients without inherited bleeding disorders or anticoagulant use undergoing non-cardiac surgery or invasive procedures.
Huber J; Stanworth SJ; Doree C; Fortin PM; Trivella M; Brunskill SJ; Hopewell S; Wilkinson KL; Estcourt LJ
Cochrane Database Syst Rev; 2019 Nov; 11(11):CD012745. PubMed ID: 31778223
[TBL] [Abstract][Full Text] [Related]
35. Pro-coagulant haemostatic factors for the prevention and treatment of bleeding in people without haemophilia.
Fabes J; Brunskill SJ; Curry N; Doree C; Stanworth SJ
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD010649. PubMed ID: 30582172
[TBL] [Abstract][Full Text] [Related]
36. Tranexamic acid for patients with nasal haemorrhage (epistaxis).
Joseph J; Martinez-Devesa P; Bellorini J; Burton MJ
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD004328. PubMed ID: 30596479
[TBL] [Abstract][Full Text] [Related]
37. Comparison of a restrictive versus liberal red cell transfusion policy for patients with myelodysplasia, aplastic anaemia, and other congenital bone marrow failure disorders.
Gu Y; Estcourt LJ; Doree C; Hopewell S; Vyas P
Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD011577. PubMed ID: 26436602
[TBL] [Abstract][Full Text] [Related]
38. Antifibrinolytic drugs for acute traumatic injury.
Roberts I; Shakur H; Ker K; Coats T;
Cochrane Database Syst Rev; 2012; 12():CD004896. PubMed ID: 23418644
[TBL] [Abstract][Full Text] [Related]
39. Effect of Antifibrinolytic Therapy on Complications, Thromboembolic Events, Blood Product Utilization, and Fusion in Adult Spinal Deformity Surgery.
Soroceanu A; Oren JH; Smith JS; Hostin R; Shaffrey CI; Mundis GM; Ames CP; Burton DC; Bess S; Gupta MC; Deviren V; Schwab FJ; Lafage V; Errico TJ
Spine (Phila Pa 1976); 2016 Jul; 41(14):E879-E886. PubMed ID: 27398796
[TBL] [Abstract][Full Text] [Related]
40. Antifibrinolytic drugs for acute traumatic injury.
Roberts I; Shakur H; Ker K; Coats T;
Cochrane Database Syst Rev; 2011 Jan; (1):CD004896. PubMed ID: 21249666
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
